公司研究
Bicycle Therapeutics plc - ADR (BCYC)
正在加载 SEC 业务与财务数据…
该公司的 AI 产业关系尚待核实。
- 股票代码
- BCYC
- 交易所
- NASDAQ
- 货币
- USD
- 国家或地区
- United States
- 证券类型
- American Depositary Receipt
上市资料同步于 2026-09-10.
正在加载你的观点…
公司文章
发布观点加载中…
正在加载公司动态…
公司研究
正在加载 SEC 业务与财务数据…
该公司的 AI 产业关系尚待核实。
上市资料同步于 2026-09-10.
正在加载你的观点…
加载中…
正在加载公司动态…
估算市值
不可用
需要可用的股份数量和缓存收盘价。
年度报告，截至 2025-12-31。这些是已披露的年度数据，不是过去十二个月的估算值。
We strive to protect and enhance the proprietary technology, inventions, and improvements that are commercially important to the development of our business, including our Bicycle platform. This includes seeking, maintaining, and defending patent rights, whether developed internally or licensed from third parties, which are directed to the use of our Bicycle platform, composition of matter of bicyclic peptides identified through use of the platform and further chemical optimization, conjugates comprising such bicyclic peptides, methods of using our product candidates, and other inventions that are important to our business.
摘自第 1 项“业务”；披露于 2026-03-17。内容可能经过截取。
来源：SEC Company Facts。核查于 2026-09-25。数据在后台更新。缺失或含义不明确的数据不予展示。
当前展示此前获取的快照，最近一次刷新尚未完成。